APO Research
Talk to an analyst

APO RESEARCH · REPORT

Surgical Ablation

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Surgical Ablation Market Outlook and Growth Opportunities 2026

4 March 2026190 pages

Choose your research edition.

Industry ResearchSurgical Ablation Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Surgical Ablation Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Surgical Ablation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Surgical Ablation Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Surgical Ablation Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Surgical Ablation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Surgical Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Surgical Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Surgical Ablation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Surgical Ablation market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Surgical Ablation market include AngioDynamics, Boston Scientific Corporation, Johnson & Johnson, Medtronic, AtriCure, olympus Corporation, Smith & Nephew, Minerva Surgical and Merit Medical Systems, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Surgical Ablation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Surgical Ablation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Surgical Ablation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Surgical Ablation market.

Surgical Ablation Segment by Company

AngioDynamics

Boston Scientific Corporation

Johnson & Johnson

Medtronic

AtriCure

olympus Corporation

Smith & Nephew

Minerva Surgical

Merit Medical Systems

Biotronik SE &Co.KG

Surgical Ablation Segment by Type

Radiofrequency Ablation

Laser Ablation

Electroablation

Cryoablation

Ultrasound Ablation

Other

Surgical Ablation Segment by Application

Oncology

Cardiovascular Department

Orthopaedics

Gastroenterology

Other

Surgical Ablation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Surgical Ablation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Surgical Ablation key companies, revenue, market share, and recent developments.

3. To split the Surgical Ablation breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Surgical Ablation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Surgical Ablation significant trends, drivers, influence factors in global and regions.

6. To analyze Surgical Ablation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Surgical Ablation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Surgical Ablation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Surgical Ablation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Surgical Ablation industry.

Chapter 3: Detailed analysis of Surgical Ablation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Surgical Ablation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Surgical Ablation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Surgical Ablation Industry Trends Table 2. Surgical Ablation Industry Drivers Table 3. Surgical Ablation Industry Opportunities and Challenges Table 4. Surgical Ablation Industry Restraints Table 5. Global Surgical Ablation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Surgical Ablation Revenue Share by Company (2021-2026) Table 7. Global Surgical Ablation Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Surgical Ablation Key Company Manufacturing Base & Headquarters Table 9. Global Surgical Ablation Company, Product Type & Application Table 10. Global Surgical Ablation Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Surgical Ablation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Radiofrequency Ablation Table 15. Significant Companies of Laser Ablation Table 16. Significant Companies of Electroablation Table 17. Significant Companies of Cryoablation Table 18. Significant Companies of Ultrasound Ablation Table 19. Significant Companies of Other Table 20. Global Surgical Ablation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Surgical Ablation Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Surgical Ablation Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Surgical Ablation Sales Value Share by Type (2021-2026) Table 24. Global Surgical Ablation Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Oncology Table 26. Significant Companies of Cardiovascular Department Table 27. Significant Companies of Orthopaedics Table 28. Significant Companies of Gastroenterology Table 29. Significant Companies of Other Table 30. Global Surgical Ablation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Surgical Ablation Sales Value by Application (2021-2026) & (US$ Million) Table 32. Global Surgical Ablation Sales Value by Application (2027-2032) & (US$ Million) Table 33. Global Surgical Ablation Sales Value Share by Application (2021-2026) Table 34. Global Surgical Ablation Sales Value Share by Application (2027-2032) Table 35. Global Surgical Ablation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Surgical Ablation Sales Value by Region (2021-2026) & (US$ Million) Table 37. Global Surgical Ablation Sales Value Share by Region (2021-2026) Table 38. Global Surgical Ablation Sales Value by Region (2027-2032) & (US$ Million) Table 39. Global Surgical Ablation Sales Value Share by Region (2027-2032) Table 40. Global Surgical Ablation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 41. Global Surgical Ablation Sales Value by Country (2021-2026) & (US$ Million) Table 42. Global Surgical Ablation Sales Value Market Share by Country (2021-2026) Table 43. Global Surgical Ablation Sales Value by Country (2027-2032) & (US$ Million) Table 44. Global Surgical Ablation Sales Value Market Share by Country (2027-2032) Table 45. AngioDynamics Company Information Table 46. AngioDynamics Business Overview Table 47. AngioDynamics Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. AngioDynamics Surgical Ablation Product Portfolio Table 49. AngioDynamics Recent Development Table 50. Boston Scientific Corporation Company Information Table 51. Boston Scientific Corporation Business Overview Table 52. Boston Scientific Corporation Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Boston Scientific Corporation Surgical Ablation Product Portfolio Table 54. Boston Scientific Corporation Recent Development Table 55. Johnson & Johnson Company Information Table 56. Johnson & Johnson Business Overview Table 57. Johnson & Johnson Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Johnson & Johnson Surgical Ablation Product Portfolio Table 59. Johnson & Johnson Recent Development Table 60. Medtronic Company Information Table 61. Medtronic Business Overview Table 62. Medtronic Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Medtronic Surgical Ablation Product Portfolio Table 64. Medtronic Recent Development Table 65. AtriCure Company Information Table 66. AtriCure Business Overview Table 67. AtriCure Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. AtriCure Surgical Ablation Product Portfolio Table 69. AtriCure Recent Development Table 70. olympus Corporation Company Information Table 71. olympus Corporation Business Overview Table 72. olympus Corporation Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. olympus Corporation Surgical Ablation Product Portfolio Table 74. olympus Corporation Recent Development Table 75. Smith & Nephew Company Information Table 76. Smith & Nephew Business Overview Table 77. Smith & Nephew Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Smith & Nephew Surgical Ablation Product Portfolio Table 79. Smith & Nephew Recent Development Table 80. Minerva Surgical Company Information Table 81. Minerva Surgical Business Overview Table 82. Minerva Surgical Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Minerva Surgical Surgical Ablation Product Portfolio Table 84. Minerva Surgical Recent Development Table 85. Merit Medical Systems Company Information Table 86. Merit Medical Systems Business Overview Table 87. Merit Medical Systems Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Merit Medical Systems Surgical Ablation Product Portfolio Table 89. Merit Medical Systems Recent Development Table 90. Biotronik SE &Co.KG Company Information Table 91. Biotronik SE &Co.KG Business Overview Table 92. Biotronik SE &Co.KG Surgical Ablation Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Biotronik SE &Co.KG Surgical Ablation Product Portfolio Table 94. Biotronik SE &Co.KG Recent Development Table 95. Research Programs/Design for This Report Table 96. Authors List of This Report Table 97. Secondary Sources Table 98. Primary Sources List of Figures Figure 1. Surgical Ablation Product Image Figure 2. Global Surgical Ablation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Surgical Ablation Market Size (2021-2032) & (US$ Million) Figure 4. Global Surgical Ablation Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Radiofrequency Ablation Image Figure 8. Laser Ablation Image Figure 9. Electroablation Image Figure 10. Cryoablation Image Figure 11. Ultrasound Ablation Image Figure 12. Other Image Figure 13. Global Surgical Ablation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Surgical Ablation Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Surgical Ablation Sales Value Share by Type (2021-2032) Figure 16. Oncology Image Figure 17. Cardiovascular Department Image Figure 18. Orthopaedics Image Figure 19. Gastroenterology Image Figure 20. Other Image Figure 21. Global Surgical Ablation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Surgical Ablation Sales Value Share 2021 VS 2025 VS 2032 Figure 23. Global Surgical Ablation Sales Value Share by Application (2021-2032) Figure 24. Global Surgical Ablation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 25. Global Surgical Ablation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 26. North America Surgical Ablation Sales Value (2021-2032) & (US$ Million) Figure 27. North America Surgical Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Europe Surgical Ablation Sales Value (2021-2032) & (US$ Million) Figure 29. Europe Surgical Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Asia-Pacific Surgical Ablation Sales Value (2021-2032) & (US$ Million) Figure 31. Asia-Pacific Surgical Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 32. South America Surgical Ablation Sales Value (2021-2032) & (US$ Million) Figure 33. South America Surgical Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Middle East & Africa Surgical Ablation Sales Value (2021-2032) & (US$ Million) Figure 35. Middle East & Africa Surgical Ablation Sales Value Share by Country (%), 2025 VS 2032 Figure 36. USA Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. USA Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. USA Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Canada Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Canada Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Canada Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Mexico Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Mexico Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Mexico Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Germany Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Germany Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Germany Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. France Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. France Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. France Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. U.K. Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. U.K. Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. U.K. Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Italy Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Italy Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Italy Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Spain Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Spain Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Spain Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Russia Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Russia Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Russia Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Netherlands Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Netherlands Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Netherlands Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Nordic Countries Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Nordic Countries Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Nordic Countries Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. China Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. China Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. China Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Japan Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Japan Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Japan Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. South Korea Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. South Korea Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. South Korea Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. India Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. India Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. India Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Australia Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Australia Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Australia Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Southeast Asia Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Southeast Asia Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Southeast Asia Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Brazil Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Brazil Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Brazil Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Argentina Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Argentina Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Argentina Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Chile Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Chile Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Chile Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Colombia Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Colombia Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Colombia Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Peru Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Peru Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Peru Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Saudi Arabia Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Israel Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Israel Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Israel Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. UAE Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. UAE Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. UAE Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Turkey Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Turkey Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Turkey Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Iran Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Iran Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Iran Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Egypt Surgical Ablation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Egypt Surgical Ablation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Egypt Surgical Ablation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Years Considered Figure 121. Research Process Figure 122. Key Executives Interviewed

Scope & coverage.

Types
  • Radiofrequency Ablation
  • Laser Ablation
  • Electroablation
  • Cryoablation
  • Ultrasound Ablation
  • Other
Applications
  • Oncology
  • Cardiovascular Department
  • Orthopaedics
  • Gastroenterology
  • Other
Companies covered
  • AngioDynamics
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic
  • AtriCure
  • olympus Corporation
  • Smith & Nephew
  • Minerva Surgical
  • Merit Medical Systems
  • Biotronik SE &Co.KG

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Surgical Ablation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Surgical Ablation Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Surgical Ablation Market Dynamics
  1. 2.1 Surgical Ablation Industry Trends
  2. 2.2 Surgical Ablation Industry Drivers
  3. 2.3 Surgical Ablation Industry Opportunities and Challenges
  4. 2.4 Surgical Ablation Industry Restraints
3 Surgical Ablation Market by Company
  1. 3.1 Global Surgical Ablation Company Revenue Ranking in 2025
  2. 3.2 Global Surgical Ablation Revenue by Company (2021-2026)
  3. 3.3 Global Surgical Ablation Company Ranking (2024-2026)
  4. 3.4 Global Surgical Ablation Company Manufacturing Base and Headquarters
  5. 3.5 Global Surgical Ablation Company Product Type and Application
  6. 3.6 Global Surgical Ablation Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Surgical Ablation Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Surgical Ablation Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Surgical Ablation Market by Type
  1. 4.1 Surgical Ablation Type Introduction
  2. 4.1.1 Radiofrequency Ablation
  3. 4.1.2 Laser Ablation
  4. 4.1.3 Electroablation
  5. 4.1.4 Cryoablation
  6. 4.1.5 Ultrasound Ablation
  7. 4.1.6 Other
  8. 4.2 Global Surgical Ablation Sales Value by Type
  9. 4.2.1 Global Surgical Ablation Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Surgical Ablation Sales Value by Type (2021-2032)
  11. 4.2.3 Global Surgical Ablation Sales Value Share by Type (2021-2032)
5 Surgical Ablation Market by Application
  1. 5.1 Surgical Ablation Application Introduction
  2. 5.1.1 Oncology
  3. 5.1.2 Cardiovascular Department
  4. 5.1.3 Orthopaedics
  5. 5.1.4 Gastroenterology
  6. 5.1.5 Other
  7. 5.2 Global Surgical Ablation Sales Value by Application
  8. 5.2.1 Global Surgical Ablation Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Surgical Ablation Sales Value by Application (2021-2032)
  10. 5.2.3 Global Surgical Ablation Sales Value Share by Application (2021-2032)
6 Surgical Ablation Regional Value Analysis
  1. 6.1 Global Surgical Ablation Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Surgical Ablation Sales Value by Region (2021-2032)
  3. 6.2.1 Global Surgical Ablation Sales Value by Region: 2021-2026
  4. 6.2.2 Global Surgical Ablation Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Surgical Ablation Sales Value (2021-2032)
  7. 6.3.2 North America Surgical Ablation Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Surgical Ablation Sales Value (2021-2032)
  10. 6.4.2 Europe Surgical Ablation Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Surgical Ablation Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Surgical Ablation Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Surgical Ablation Sales Value (2021-2032)
  16. 6.6.2 South America Surgical Ablation Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Surgical Ablation Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Surgical Ablation Sales Value Share by Country, 2025 VS 2032
7 Surgical Ablation Country-level Value Analysis
  1. 7.1 Global Surgical Ablation Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Surgical Ablation Sales Value by Country (2021-2032)
  3. 7.2.1 Global Surgical Ablation Sales Value by Country (2021-2026)
  4. 7.2.2 Global Surgical Ablation Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Surgical Ablation Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Surgical Ablation Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Surgical Ablation Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Surgical Ablation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Surgical Ablation Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Surgical Ablation Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Surgical Ablation Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Surgical Ablation Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Surgical Ablation Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Surgical Ablation Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Surgical Ablation Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Surgical Ablation Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Surgical Ablation Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Surgical Ablation Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Surgical Ablation Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Surgical Ablation Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Surgical Ablation Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Surgical Ablation Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Surgical Ablation Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Surgical Ablation Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Surgical Ablation Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Surgical Ablation Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Surgical Ablation Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Surgical Ablation Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Surgical Ablation Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Surgical Ablation Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Surgical Ablation Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Surgical Ablation Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Surgical Ablation Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Surgical Ablation Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Surgical Ablation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AngioDynamics
  2. 8.1.1 AngioDynamics Company Information
  3. 8.1.2 AngioDynamics Business Overview
  4. 8.1.3 AngioDynamics Surgical Ablation Revenue and Gross Margin (2021-2026)
  5. 8.1.4 AngioDynamics Surgical Ablation Product Portfolio
  6. 8.1.5 AngioDynamics Recent Developments
  7. 8.2 Boston Scientific Corporation
  8. 8.2.1 Boston Scientific Corporation Company Information
  9. 8.2.2 Boston Scientific Corporation Business Overview
  10. 8.2.3 Boston Scientific Corporation Surgical Ablation Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Boston Scientific Corporation Surgical Ablation Product Portfolio
  12. 8.2.5 Boston Scientific Corporation Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Surgical Ablation Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Surgical Ablation Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Medtronic
  20. 8.4.1 Medtronic Company Information
  21. 8.4.2 Medtronic Business Overview
  22. 8.4.3 Medtronic Surgical Ablation Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Medtronic Surgical Ablation Product Portfolio
  24. 8.4.5 Medtronic Recent Developments
  25. 8.5 AtriCure
  26. 8.5.1 AtriCure Company Information
  27. 8.5.2 AtriCure Business Overview
  28. 8.5.3 AtriCure Surgical Ablation Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AtriCure Surgical Ablation Product Portfolio
  30. 8.5.5 AtriCure Recent Developments
  31. 8.6 olympus Corporation
  32. 8.6.1 olympus Corporation Company Information
  33. 8.6.2 olympus Corporation Business Overview
  34. 8.6.3 olympus Corporation Surgical Ablation Revenue and Gross Margin (2021-2026)
  35. 8.6.4 olympus Corporation Surgical Ablation Product Portfolio
  36. 8.6.5 olympus Corporation Recent Developments
  37. 8.7 Smith & Nephew
  38. 8.7.1 Smith & Nephew Company Information
  39. 8.7.2 Smith & Nephew Business Overview
  40. 8.7.3 Smith & Nephew Surgical Ablation Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Smith & Nephew Surgical Ablation Product Portfolio
  42. 8.7.5 Smith & Nephew Recent Developments
  43. 8.8 Minerva Surgical
  44. 8.8.1 Minerva Surgical Company Information
  45. 8.8.2 Minerva Surgical Business Overview
  46. 8.8.3 Minerva Surgical Surgical Ablation Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Minerva Surgical Surgical Ablation Product Portfolio
  48. 8.8.5 Minerva Surgical Recent Developments
  49. 8.9 Merit Medical Systems
  50. 8.9.1 Merit Medical Systems Company Information
  51. 8.9.2 Merit Medical Systems Business Overview
  52. 8.9.3 Merit Medical Systems Surgical Ablation Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Merit Medical Systems Surgical Ablation Product Portfolio
  54. 8.9.5 Merit Medical Systems Recent Developments
  55. 8.10 Biotronik SE &Co.KG
  56. 8.10.1 Biotronik SE &Co.KG Company Information
  57. 8.10.2 Biotronik SE &Co.KG Business Overview
  58. 8.10.3 Biotronik SE &Co.KG Surgical Ablation Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Biotronik SE &Co.KG Surgical Ablation Product Portfolio
  60. 8.10.5 Biotronik SE &Co.KG Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst